Myriad Genetics Presents Pivotal Validation Study for New riskScore™ Test at the 2017 San Antonio Breast Cancer Symposium December 06,…

Myriad Genetics Presents Pivotal Validation Study for New riskScore™ Test at the 2017 San Antonio Breast Cancer Symposium December 06,…
Widespread infections caused by viruses are commonly known as viral diseases. Common types of viral diseases include cold, influenza, chickenpox,…
Vaccines are one of the most cost effective and powerful health interventions available. Billions of people from around the world…
Common types of viral diseases include cold, influenza, chickenpox, HIV/AIDS, viral hepatitis, HPV, viral meningitis, herpes, etc. These diseases are…
Sandoz proposed biosimilar rituximab accepted for review by the FDA September 12, 2017 Sandoz, a Novartis Division, and the pioneer…
Bristol-Myers Squibb Receives FDA Approval for Opdivo (nivolumab) in MSI-H or dMMR Metastatic Colorectal Cancer That Has Progressed Following…
Many new medications and treatments have emerged this year for improving the management and prognoses of patients suffering from serious…
Repatha® (Evolocumab) Phase 3 Cognitive Function Study Results Published In The New England Journal Of Medicine August 16, 2017 Amgen has…
FibroGen Announces Positive Topline Results from Phase 2 Study of Pamrevlumab in Idiopathic Pulmonary Fibrosis Aug. 07, 2017 FibroGen, Inc.,…
Amgen and Array BioPharma Announce Preclinical License And Collaboration Agreement In Inflammation July 18, 2017 Amgen and Array BioPharma have announced a collaboration…
Phase 3 Study Evaluating the Safety and Efficacy of Adjuvant Opdivo in Resected High-Risk Melanoma Patients Meets Primary Endpoint July 5, 2017…
AbbVie Announces Pivotal Phase 2 Trial Evaluating VENCLYXTO™ (venetoclax) in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) June 23, 2017…
Prominent pharmaceutical companies are renowned for their commitment toward innovation, and they spend heavily on R&D. Here is the list…
Best Pharmaceutical News January 2017 by IgeaHub.com – All the Pharma Top News Stories, Analyses and Perspectives
ABBVIE ANNOUNCES FOUR NEW GLOBAL RESEARCH COLLABORATIONS January 9, 2017 AbbVie, a global biopharmaceutical company, has announced four new collaborations…